Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-09-03
2009-12-29
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C424S186100, C424S232100
Reexamination Certificate
active
07638481
ABSTRACT:
The present invention relates to the treatment of spinal cord injury with a vaccinia virus complement control protein (VCP).
REFERENCES:
patent: 6140472 (2000-10-01), Rosengard et al.
Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injuries: Chapter 9. Pharmacological Therapy after Acute Cervical Spinal Cord Injury. Neurosurgery Online, vol. 50(3) Supplement, Mar. 2002, pp. S63-S72.
Uvarova et al (Virus Research 81:39-45, 2001).
Miller et al (Virology 229:126-133, 1997).
Hicks et al (Journal of Neurotrama 19:705-714, 2002).
Massung et al., “Terminal Region Sequence Variations in Variola Virus DNA,”Virology, 1996, 221:291-300.
McDonald, “Repairing the Damaged Spinal Cord,”Scientific American, 1999, 281:64-73.
McKenzie et al., “Regulation of Complement Activity by Vaccinia Virus Complement-Control Protein,”J. Infect. Dis., 1992, 166:1245-1250.
Miller et al., “Severe and Prolonged Inflammatory Response to Localized Cowpox Virus Infection in Footpads of C5-Deficient Mice: Investigation of the Role of Host Complement in Poxvirus Pathogenesis,”Cell. Immunol., 1995, 162:326-332.
Miller et al., “The Cowpox Virus-Encoded Homolog of the Vaccinia Virus Complement Control Protein in an Inflammation Modulatory Protein,”Virology, 1997, 229:126-133.
Popovich et al., “Cellular Inflammatory Response After Spinal Cord Injury in Sprague-Dawley and Lewis Rats,”J. Comp. Neurol., 1997, 377:443-464.
Popovich et al., “Depletion of Hematogenous Macrophages Promotes Partial Hindlimb Recovery and Neuroanatomical Repair after Experimental Spinal Cord Injury,”Exp. Neurol., 1999, 158:351-365.
Popovich and Hickey, “Bone Marrow Chimeric Rats Reveal the Unique Distribution of Resident and Recruited Macrophages in the Contused Rat Spinal Cord,”J. Neuropathol. Exp. Neurol., 2001, 60(7):676-685.
Popovich et al., “The Neuropathological and Behavioral Consequences of Intraspinal Microglial/Macrophage Activation,”J. Neuropathol. Exp. Neurol., 2002, 61(7):623-633.
Reynolds et al., “Heparin Binding Activity of Vaccinia Virus Protein Confers Additional Properties of Uptake and by Mast Cells and Attachment to Endothelial Cells,”Advances In Animal Virology, 1998, Jameel and Villarreal (eds.), Science Publishers, pp. 337-342.
Reynolds et al., “Vaccinia Virus Complement Control Protein Modulates Inflammation Following Spinal Cord Injury,”Ann. N.Y. Acad. Sci., 2003, 1010:534-539.
Reynolds et al., “Vaccinia Virus Complement Control Protein Reduces Inflammation and Improves Spinal Cord Integrity Following Spinal Cord Injury,”Ann. N.Y. Acad. Sci., 2004, 1035:165-178.
Rosengard et al., “Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement,”Proc. Natl. Acad. Sci. USA, 2002, 99(13):8808-8813.
Smith et al., “Conserved Surface-Exposed K/R-X-K/R Motifs and Net Positive Charge on Poxvirus Complement Control Proteins Serve as Putative Heparin Binding Sites and Contribute to Inhibition of Molecular Interactions with Human Endothelial Cells: a Novel Mechanism for Evasion of Host Defense,”J. Virol., 2000, 74(12):5659-5666.
Uvarova and Shchelkunov, “Species-specific differences in the structure of orthopoxvirus complement-binding protein,”Virus Research, 2001, 81:39-45.
Vasquez et al., “Spinal Prostaglandins Are Involved in the Development But Not the Maintenance of Inflammation-Induced Spinal Hyperexcitability,”J. Neurosci., 2001, 21(22):9001-9008.
Watanabe et al., “Differential Activation of Microglia After Experimental Spinal Cord Injury,”J. Neurotrauma, 1999, 16(3):255-265.
Anderson, “Mechanisms and pathways of inflammatory responses in CNS trauma: spinal cord injury,”J. Spinal Cord Med., 2002, 25:70-79.
Bracken, “Methylprednisolone and Acute Spinal Cord Injury: An Update of the Randomized Evidence,”Spine, 2001, 26(24S):S47-S54.
Dumont et al., “Acute Spinal Cord Injury, Part I: Pathophysiologic Mechanisms,”Clin. Neuropharmacol., 2001, 24(5):254-264.
Farooque et al., “Improved recovery after spinal cord trauma in ICAM-1 and P-selectin knockout mice,”NeuroReport, 1999, 10:131-134.
Fitch et al., “Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma,”1999, J. Neuroscience, 19:8182-8198.
Goebel et al., “The Complete DNA Sequence of Vaccinia Virus,”Virology, 1990, 179:247-266.
Guth et al., “Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury,”Proc. Natl. Acad. Sci. USA, 1994, 91:12308-12312.
Hurlbert, “Methylprednisolone for acute spinal cord injury: an inappropriate standard of care,”J. Neurosurg. (Spine 1), 2000, 93:1-7.
Hurlbert, “The Role of Steroids in Acute Spinal Cord Injury: An Evidence-Based Analysis,”Spine, 2001, 26(24S):S39-S46.
Jha and Kotwal, “Vaccinia complement control protein: Multi-functional protein and a potential wonder drug,”J. Biosci., 2003, 28(3):265-271.
Keeling et al., “Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system,”J. Neuroimmunol., 2000, 105:20-30.
Kotwal and Moss, “Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins,”Nature, 1988, 335:176-178.
Kotwal et al., “Mapping and Insertional Mutagenesis of a Vaccinia Virus Gene Encoding a 13,800-Da Secreted Protein,”Virology, 1989, 171:579-587.
Kotwal et al., “Inhibition of the Complement Cascade by the Major Secretory Protein of Vaccinia Virus,”Science, 1990, 250:827-830.
Kotwal et al., “The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation,”Mol. Cell. Biochem., 1998, 185:39-46.
Kotwal et al., “Vaccinia virus complement control protein is a virokine with lysozyme-like heparin-binding activity: possible implications in prolonged evasion of host immune response,”Proc. 10th Intl. Cong. Immunol., Nov. 1-6, 1998, New Delhi, India pp. 315-320.
Lacroix et al., “Delivery of Hyper-Interleukin-6 to the Injured Spinal Cord Increases Neutrophil and Macrophage Infiltration and Inhibits Axonal Growth,”J. Comp. Neurol., 2002, 454:213-228.
Liu et al., “Heme Oxygenase-1 Expression after Spinal Cord Injury: The Induction in Activated Neutrophils,”J. Neurotrauma, 2002, 19(4):479-490.
Massung et al., “Analysis of the Complete Genome of Smallpox Variola Major Virus Strain Bangladesh-1975,”Virology, 1994, 201:215-240.
Fish & Richardson P.C.
Mosher Mary E
University of Louisville Research Foundation Inc.
LandOfFree
Treatment of spinal cord injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of spinal cord injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of spinal cord injury will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4102426